Beruflich Dokumente
Kultur Dokumente
Tetrahedron
journal homepage: www.elsevier.com/locate/tet
a r t i c l e i n f o
Article history:
Received 6 September 2011
Available online 6 October 2011
Contents
1.
2.
3.
4.
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16
Classification of carbamates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17
Methods of preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17
3.1.
Phosgenation technique . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
3.2.
Reductive carbonylation of nitroaromatics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
3.3.
Oxidative carbonylation of amines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.4.
Using metal/non-metal carbonates/bicarbonates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.5.
Synthesis of carbamates using carbon dioxide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.5.1.
Gaseous carbon dioxide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.5.2.
Electrochemical carbon dioxide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.5.3.
Supercritical carbon dioxide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.5.4.
Organic carbonates with carbon dioxide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.6.
Carbamate synthesis from dithiocompounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.6.1.
Using dithiocarbamates/thiocarbamates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.6.2.
From carbon-imido dithiolates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.7.
Carbamate synthesis through rearrangement reactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.7.1.
Hoffmann rearrangement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.7.2.
Curtius rearrangement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.7.3.
Lossen rearrangement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.8.
Miscellaneous methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.8.1.
Carbamate synthesis using carbonyl di-imidazole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.8.2.
Carbamate synthesis using sodium cyanate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.8.3.
Carbamates synthesis using Burgess reagent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.8.4.
Carbamate synthesis through transcarbamoylation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.8.5.
Carbamate synthesis using ureas and alcohols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.8.6.
Carbamate synthesis from carbonyl compounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.8.7.
Carbamate synthesis from oximes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
References and notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Biographical sketch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
16
1. Introduction
Organic carbamates are a stable class of compounds derived
from the unstable carbamic acid (H2NeCOOH) by substitution of
the amino and carboxyl moieties with various kinds of structurally
diverse alkyl/aryl, aryl/alkyl or substituted alkyl/aryl and aryl/alkyl
groups, and are identied by the presence of the linkage
OeCOeNHe.1,2 When the carbamate linkage is present in a cyclic
system, this class of compounds are referred to as cyclic carbamates.3 When the carbamate group is attached to any inorganic
atom, either metallic or nonmetallic, such compounds are referred
to as inorganic carbamates.4
Organic carbamates represent an important class of compounds
showing various interesting properties. They nd wide utility in
areas, such as pharmaceuticals,5 agrochemicals6 (pesticides, herbicides, insecticides, fungicides etc.), as intermediates in organic
synthesis,7 for the protection of amino groups in peptide chemistry,8 and as linkers in combinatorial chemistry.9 Functionalisation
of amines as carbamates offers an attractive method for the generation of derivatives, which may have interesting medicinal and
biological properties.10 Organic carbamates have been extensively
used as intermediate for the synthesis of structurally diverse synthetic intermediates/molecules of biological signicance.11 Therefore, considerable interest has been generated in the recent past in
the development of efcient and safe methodologies for carbamate
ester synthesis.
Organic carbamates have frequently been employed as pharmaceuticals in the forms of drugs and prodrugs.5a,12a In recent
years, several reports have indicated that the carbamate linkage
present in the active pharmacophores of various structurally diverse molecules increases the biological activities of semisynthetic/
synthetic natural/synthetic molecules.13 Furthermore, the role of
the carbamate linkage has been extensively studied in structurally
diverse natural/semisynthetic molecules against various diseases,
such as anticancer, antibacterial, antifungal, antimalarial, antiviral,
O
OH O
O
NH
OH
H3CHN
O
OH
OH O
AcO
N
Cl
NH
NH2
Cl
Capravirine: anti-HIV
O
O
NHCH3
O
Carbaryl: Insecticide
O HO
17
O
O
O
O
O
HN
NH2
OMe
MeO
H2N
OH
O
NH
PPI-2458
MeO
O
Geldanamycin
OH
OH
O
O
O
HN
HN
OH
H
N
O
O
OMe
R
MeO
N
H
CH3
O
NH
NH
Staurosporine derivatives
Podophyllotoxin analogues
2. Classication of carbamates
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
R1NH2 +
4
+ R2OH
5
(either 1 or 2 or 3)
X
Cl
O
Cl
3
O
3. Methods of preparation
3.1. Phosgenation technique
Cl
NHR1
OR2
Scheme 1.
18
HO
HO
O
OMe
OMe
N
O
HO
HO
O
NH
O
O
NH
OMe
O
O
Erythromycin derivatives
N
R2
HO
HN
O
HO
OH
OH
O
O
O
HO
O
O
NH
O
NH
O
OMe
R1
O
O
Azithromycin derivatives
HN
O
O
COOH
XAc
Scheme 2.
R1NH2 + ClCOOR2
7
4
O
OH
BTC
Pyr
Cl
O
O
R2O
10
OCH2R2
75-99% R1 NH2
4
O
R2O
NHR1
NHR1
6
Scheme 3.
5
R2OH
Pyr
yttria-zirconia based
Lewis acid catalyst
rt, 5 min-6 h, 88-96%
Scheme 4.
19
HO
CF3
N
HN
Cl
NH
Antioxidant
Antimalarial
OH
F3C
Cl
HO
N
H
O
NH
O
F
N
H
Antiinflammatory
Antidiabetic
O
F
H
N
Ph
O
COOH
O
O
COOR
Antitubercular
Fig. 4. Biologically potent carbamates of natural/synthetic molecules.
Raje and co-workers have reported67 an efcient, one-pot synthesis of N-substituted (3-oxobutyl) carbamates 12, via tandem
condensation of primary amines 4 with methyl chloroformate 7
(R2Me) followed by conjugate addition of the resulting carbamates with methyl vinyl ketone 11 in the presence of Sn4 modied
zeolite Hb (Hb-SnA) at room temperature (Scheme 5).
O
11
R1NH2 + ClCOOR2
4
7
24 h, 68-75%
R1NCOOR2
12
Scheme 5.
More recently, Kim and Jung have reported68 a simple and efcient synthesis of carbamates 6, through reacting equimolar
amounts of amines 4, chloroformates 7 and indium metal (Scheme
6). Thus, carbamates of structurally diverse substituted aliphatic,
aromatic and heterocyclic amines were prepared using various
kinds of chloroformates.
O
O
+
Cl
Cl
R1NH2
R1-N=C=O
13
+ R2OH
- R2OH
R2O
NHR1
Scheme 7.
In
R1NH2 + Cl
4
OR2
rt, 7-12 h,
73-91%
R2O
NHR1
R2 = - CH3, -CH=CH2, Bn
Scheme 6.
20
O
Cl
Et
H
N
Cl
Et
NH
O
NH
Antiprogestational
O
O
NH
R2
O
R1
OMe
MeO
CNS-Active
OH
Anti-HIV
O
O
NH
N
H
NH
O
N
N
Anticoagulant
HO
Antiestrogenic
Fig. 5. Biologically potent carbamates of natural/synthetic molecules.
a mechanism using Ru(dppe)(CO)3 17 dppebis(diphenylphosphino)ethane as a catalyst through the involvement of intermediates 18e22,
in which an aromatic amine 4 is suggested as a linker intermediate
(Scheme 10).
Ph2.P
Scheme 8.
For a reductive carbonylation of aromatic nitrocompounds carried out in alcohols, it might generally be considered that the carbamates16 are formed by the reaction of aromatic isocyanates
ArNCO, with an alcohol ReOH, outside the coordination sphere of
the metal.87 However, Cenini has found in the case of Ru3(CO)12
with NEt4Cl as a co-catalyst that the alcohol participates in the
catalytic cycle, since, when it was absent, practically no isocyanate
was obtained (Scheme 9).
+ ArNO2
P.Ph2
-CO2 OC
Ph2.P
O
Ru
N
OC CO
Ar
NH-Ar
LnM
CO
COOR'
OR'
Ar-HN
+ LnMC=O
16
Scheme 9.
OC
P.Ph2
O
Ru
-ArNH2
N
CO
Ar
-CO2
O
19
P.Ph2
Ru
CO
OC
17
CO
OMe
OH
22
Ph2.P
+ CO
O
CO, R'OH
Ph2.P
Ru CO
18
Ph2.P
LnM=N-Ar
P.Ph2
P.Ph2
OMe
ArN=C=O
+ArNH2
Ru
Ph2.P
P.Ph2
O
N H
Ar
OC CO
O 21
-MeOH
COOMe
Ru
OC
CO
Ar-CO-NH.Ar
ArNH2
R1NH2
4
COOMe
20
O
Ar-NH
OR'
16
Scheme 10.
21
Carbamates
In o rg a n ic
O rg an ic
Saturated
Non metal
Metal
Unsaturated
Symmetrical Unsymmetrical
Aliphatic
Aromatic
Aliphatic-aromatic
Simple
Others
Substituted
Simple
Activated
Cyclic
Simple
Functional
Imido
Thio
Symmetrical
Pyro
Linear-alicyclic
Alicyclic
Branched
Linear
Ortho
Unsymmetrical
Symmetrical Unsymmetrical
S im p le
S u b s t it u t e d
[(PPh3)2N]
Ar-NO2
O=C
[(Rh(CO)4]
23
+ CO, ArNH2
O=C
O=C
COOMe
Rh
Rh
24
O=C
Ar
27
COOMe
O=C
+ CO
O
Rh
O=C
O=C
CO2
Rh
Ar
O=C
25
Ar
26
Scheme 11.
O
NO2
14
HN
+ ClCOOEt or (Boc)2O
28
OR'
Sn/NH4Cl
MeOH, ultrasound
79-93%
15
22
+ ClCOOR2
14
OR2
Zn/NH4Cl
R2OH
5
29
R1NH2 + CO + R2OH
4
5
HOR2 + 1/2 O2
metal cat.
R2O
R1NHCOOR2
6
CO +
O2
PdCl2-ZrO2-SO4
Scheme 18.
R1-NHCOOR2
6
Scheme 17.
Scheme 13.
R1NH2 +
O2
PVP-PdCl2-MXn
NaOMe, 89-97%
R1-NH2 + CO +
NHR1
R1NH2 + CO + R2OH
4
5
O2
Au/Polymer
R1NHCOOR2
6
Scheme 19.
Later, Shi and co-workers have also reported110 a highyielding efcient carbonylation of amines 4 with variety of alcohols 5 using a palladium complex-ionic liquid to afford carbamates 6. The desired products could be precipitated by adding
water into the resulting reaction mixture and the catalysts system could be reused with only a slight loss of catalytic activity
(Scheme 20).
Scheme 14.
O2
R1NHCOOR2
R1NH2 + CO + R2OH
Pd(phen)Cl
2-[Bmim]BF4
5
6
4
Scheme 20.
O
R1NH2 +
CO +
HOR2 + I2
Pd cat.
R2O
NHR1
Scheme 15.
Mizuno and co-workers have reported106 the synthesis of 2oxazolidinone derivatives in which 2-aminoethanols 30 were easily subjected to thiocarboxylation with CO promoted by elemental
sulfur followed by oxidative cyclisation with molecular oxygen to
afford the corresponding 2-oxazolidinones 31 in good yields under
mild reaction conditions (Scheme 16).
O2
R1NH2 + CO + R2OH
Co(salen)in
zeolite
5
4
R1NHCOOR2
6
Scheme 21.
23
Se
NH
OR
Et3N, 6 h, up to 85%
5
4
6
Scheme 22.
Et4NHCO3
NH + R3.X
R2
32
O
NH + R3X
R2
32
(n-Bu)NHSO4
K2CO3
R1
N
R2
OR3
HN
Et4NHCO3
R2
OR3
( )n
35
N.R3
R2
34
R1
53-98%
Br-CH2(CH2)n-NH2.HBr
R1
R1
R1
n = 1, 56%
n = 2, 42%
Scheme 26.
33
Scheme 23.
Sodium carbonate has also been used in the synthesis of carbamates.114 Moreover, this method was not efcient for the production of only O-alkylated carbamates 6, due to the formation of
N-alkylated amines 33 (Scheme 24).
O
R1
NH + R3X
R2
Na2CO3
R1
N
R2
32
R1
OR3
NR3
+
R2
33
Scheme 24.
O
R1
NH + R3X
R2
Cs2CO3
R1
N
R2
32
R1
OR3
6
44-96%
NR3
+
R2
33
R-NH-COOH
R-NH2 + CO2
36
4
37
Scheme 27.
Yoshida and co-workers have reported122 the synthesis of carbamates 6, starting from CO2 36, amines 4 and unsaturated ethers
38 (Scheme 28). This method limits the carbamate synthesis to
those produced from secondary aliphatic amines. Moreover, it required longer reaction times (w70e80 h) and afforded low yields
(3e12%).
0-19%
Scheme 25.
O
R2NH + CO2 + CH2=CH-O-Et
Several bicarbonates have been used for the synthesis of carbamates. Of these, sodium bicarbonate (NaHCO3) has found use
in peptide chemistry.116 Inesi and co-workers have reported117
the synthesis of linear carbamates 6, starting from the corresponding primary and secondary amines 4 and alkyl halides 32
using tetra-ethylammonium hydrogen carbonate (Et4NHCO3) as
the carbonyl source (Scheme 26). The yields of carbamates were
affected by the nature of the alkyl halides used. They have
further extended the methodology to the synthesis of cyclic
carbamates 35 starting from the corresponding haloamines 34
using Et4NHCO3.
36
38
~70-80 h
3-12%
R2N
OEt
6
Scheme 28.
24
O
R1
~ 45 h
NH + R3 X + CO2
R2
32
R1
6-25%
R2
36
OR3
Scheme 29.
Similarly, chloromethyl oxirane 44 or phenyl oxirane 48 on reaction with CO2 and aliphatic amines in methanol gave various
kinds of substituted carbamates127 46, 47, 50, 51 in 2e17% yields
through the involvement of intermediates 45, and 49, respectively
(Scheme 33).
Later, better yields have been reported by Yoshida and coworkers through the reaction of various epoxides 52 with a variety
of amines 4 using gaseous CO2 36 (Scheme 34).128 However, this
method leads to isomeric mixtures.
O
R1
+ CO2 +
2
52
R1
R'
NH
R''
36
HO
O
R2
R1
R'
R'
HO
R''
N
R''
R2
54
53
Scheme 34.
O
R1
R1
NH + CO2 + R3C(OR4)3
R2
R2
39
36
OR3
Scheme 30.
R1
+ CO2 +
36
OH
22-24 h
R1
42-52%
40
O C
41
OH
R1
+
N
R2
R1
52
+ CO2 +
36
R'
R''
aluminium porphyrin
NH
HO
O
R2
R'
N
53
R''
Scheme 35.
R2
42
Scheme 31.
R1
5-20%
40
Scheme 36.
OH
~ 3-4 days
O C
41
N
R2
R1 & R2 = Me
Scheme 32.
Scheme 33.
25
2 RNH2 + CO2
4
36
32
R' X
RNH-COONH3R
base, 40-78%
45
H
N
R'
O
6
Scheme 42.
Scheme 37.
O
45
R'NH-COONH3R'
O
Br
O
R'
61
R'
O
OH
OH
63
62
Scheme 43.
Scheme 38.
R-(CH2)n-CH2.X +
Scheme 39.
70
R1
R3X
32
CO2, DBU
NH
+
R2
R2
NH
DBU-CO2 complex
5 oC, 24 h, 80-98%
RNH-COONH3R
R2
R3P + CCl4
45
18-crown-6
72
73
[ R3P-CCl3] Cl
OH
R2
H
R3
PR3
O
33-93%
R2
R3
R
O
H
Scheme 45.
R'
N
6
Scheme 41.
R'
74
NHR'
CO2-Et3N
N
R'
R2
H
R3
R1
N
Scheme 44.
32
R' X
O
71
R2
Aresta and Quaranta have reported133 the synthesis of carbamates 6 employing ionic species 45 through the alkylation with
alkyl halides 32 using 18-crown-6 as a phase-transfer catalyst
(Scheme 41).
R-(CH2)n-CH2
R1
Scheme 40.
2 RNH2 + CO2
4
36
R1
N
R3
Later, Perez and co-workers have reported136 the synthesis of Nalkyl carbamates 71 in good-to-excellent yields through a clean and
mild transcarboxylation of several amines 4 with the previously
synthesised DBUeCO2 complex and subsequent O-alkylation by
different alkyl halides 70 (Scheme 44).
RNH-COONH3R
45
2 RNH2 + CO2
4
36
75
26
The use of Amberlite IRA 400 resin (basic resin) in the synthesis
of carbamates 6 in high yields through the reaction of a variety of
alcoholic tosylates 78 with various amines 4 was also reported by
our group (Scheme 51).143
R1
R2
R3
+
HN
R2
n-Bu2SnO
CO2
R2
RHN
69-99%
OH
N
O
R3
R1
X + HN
R2
R3
R1
R2
R,
R3
79
R
N
R,
Scheme 52.
A direct synthesis in high yields of carbamates 6 from the primary alcohols 5 and amines 4 using a Mitsunobu reagent/CO2
system has been rst reported by our group (Scheme 53).145
R2
77
R. (CH2)n. CH2.OH +
Scheme 47.
More recently, they have further extended their protocol for the
synthesis of carbamates 6 through the reaction of secondary
amines 4 with primary and secondary alcohols 5 using gaseous CO2
through a Mitsunobu reaction employing DBU and a DBAD/Bu3P
system (Scheme 48).140
NH
4
R1
CO2 , Ph3P/DEAD
2-4 h, 80-98%
R. (CH2)n. CH2.O
R2
Scheme 53.
R1
NH
R2
R,
R3
76
R
Mitsunobu reaction
R3
75
CO2
Scheme 51.
Scheme 46.
R2
R,
78
74
R1
R3
R'
O.Tos + HN
R1
R3
180oC, 16 h, 53-94%
OH
'
+ CO2 + HO
R3
DBU, DBAD/Bu3P
R4
R1
R3
R1
R2
R4
R3
5
32
R1
NH
R2
R-(CH2)n-CH2.
OH + HN
R2
Scheme 48.
R-(CH2)n-CH2.X +
R4
R1
N
R5
R2
NH + CO2 + RCH2CH2CH2Br
R2
O.Tos + HN
R3
R,
R3
78
Scheme 50.
O
O
R2
R5
32
zeolite-Y
cat.
R1
NCOOCH2CH2CH2R
R2
Scheme 55.
R
N
R,
R1
R1
R3
R2
R2
R4
Scheme 54.
Scheme 49.
R1
R1
dry DMSO, Mitsunobu reagent/CO2
R1
NH + CO2 + RCH2CH2CH2Br
R2
32
zeolite-based
cat.
Scheme 56.
R1
NCOOCH2CH2CH2R
R2
R1
KO2/Et4NBr/CO2
+ MeI
HN
R2
32
R1
N
R2
Sasaki and Dixneuf have also reported154 the synthesis of 2oxoalkyl substituted carbamates 85 in good yields through the reaction of secondary amines 4, a-ethynyl alcohols 84 and CO2 using
Ru3(CO)12 as the catalyst (Scheme 62).
R3
OMe
R4
OH
HN
R2
+ MeI
32
77.5-95.5%
80oC, 20 h, 4-64%
R2
R1
N
R2
OMe
+ CO2
R2NH + R
4
79
36
200oC, 24 h,
83
100oC, 8-48 h
63-80%
87
NHR1
24-90%
[Ru]/PR'3
86
R2O
C
N
100oC, 8-48 h
37-62%
tin complexes
R1
[Ru]/PR'3
R2
CH2NHR + CO2
HOR2
R4
CO2 +
85
Scheme 58.
R1NH2 +
R3
N
Scheme 62.
R1
84
KO2/Et4NBr/CO2
Ru3(CO)12
R2
Scheme 57.
R1
R1
NH + CO2 +
38-90%
27
Scheme 63.
Scheme 59.
+ CO2
+ R
HN
C
N
3-67%
79
R2
R1
Ru complex
R2
83
Scheme 64.
R2NH + R
4
+ CO2
79
RuCl3.3H2O
R1
R2
83
Scheme 61.
R1
C
N
90oC, 10-46%
Scheme 60.
NH +
(CH2)n
88
HO
R2
+ CO2
MCl3
20-38%
(CH2)n
R1
O
R2
89
84
R1 = R2 = Me
Scheme 65.
28
Dixneuf and co-workers have reported158 a regioselective synthesis of O-1-(1,3-dienyl)carbamates 91 through the regioselective
addition of CO2 and secondary amines 4 to isopropenylacetylene 90
in the presence of [Ph2P(CH2)nPPh2]Ru(h3-CH2eC(Me)]CH2)2 as
the catalyst (Scheme 66). The yields were dependent on the nature
of the ligand used in the catalyst. These workers found ligand with
n2, afforded better yields of the products. The addition is favoured
in the case of secondary cyclic amines.
R1
NH
R2
94
R1
N
R2
95
Scheme 70.
90
R2NH +
4
[ R2NCOO H2NR2]
CO2
36
100oC,
R2N
Ru cat., 20 h
45
O
O
91
up to 80%
Scheme 66.
Kim and co-workers have reported159 the synthesis of carbamates 93 through the reaction of various kinds of propargyl alcohols 92 with variety of amines 4 using gaseous CO2 in the presence
of a catalytic amount of {Cu (X) (BF4)2 (X2, 5, 19, 22, tetraaza
[6,6](1,10 )-ferrocenophane-1,5-diene)} (Scheme 67).
Later, these workers have reported the synthesis of carbamates162 6 in the solution phase through the reaction of various
kinds of structurally diverse aliphatic, aromatic and heterocyclic
amines 4 with a variety of alkyl halides 32 using the caesium carbonate/CO2 system in the presence of a catalytic amount of TBAI
(Scheme 71).
RCH2X +
R4
R2
OH +
R1
NH
R5
R3
[M]/bipy, CO2
100 C, 24 h, 30-97%
R3
RH2C
R2
Scheme 71.
R1
R4
O R
2
R1
NH
R2
32
R1
R5
92
93
They extended their methodology to the synthesis of peptidomimetics 97 and 99 using various kinds of protected amino acids 96
and 98 (Scheme 72).
Scheme 67.
Ph
H2N
COOPh
96
PhH2CO
R1
+ CO2 + HN
79
R2
[Ru(TMHD)3]
100oC, 24 h, up to 55%
R1
O
RCH2X +
32
R1
NH
R2
R2
6
Scheme 69.
COOMe
R'X
32
CO2/Cs2CO3,TBAI,
DMF, 23oC, 20 h-6 d
52-92%
N
R'
R'
O
6
Scheme 73.
A study of the comparative yields of carbamates 6 using different metal carbonates and bases on O as well as N-alkylated products was reported by Shi and Shen (Scheme 74).164 They realised
that the best yields (>87%) of carbamates could be achieved using
a DBU/CO2 system.
N
RH2C
NH
99
R1
CO2, Cs2CO3
DMF, 58-96%
PhH2CO
Scheme 72.
83
Scheme 68.
COOPh
92%
98
R2
R
COOMe
ClH2N
NH
97
87%
BzCl, CO2, Cs2CO3
Ph
BnX +
32
BnNH2
Bn
NHBn
6
Scheme 74.
We have reported165 a convenient, high-yielding, one-pot synthesis of carbamate esters (70e90%) from the corresponding
R1
RCH2OTos +
NH
R2
100
R1
RCH2 O
e , MeCN, Et4NClO4
R2
Scheme 75.
O
R1
NH + CO2 + ROH
R2
OR
up to 69%
R1
Cs2CO3
R2
29
Scheme 76.
2. CO2
O
N
3. EtI
NEt4
33-89%
102
N
H
101
R1
NH + RCH2Cl
R2
32
11
CO2
R1
75oC, 10 min,
77%
R2
DBU,
Inesi and co-workers have also reported171 an improved electrochemical synthesis of chiral oxazolidin-2-ones 75, starting from
the corresponding chiral 1,2-amino-alcohols 74. Subsequent CO2
bubbling and addition of tosyl chloride afforded the desired cyclic
carbamates 75 in high yields (Scheme 81).
OH
H2N
MeCN-Et4NClO4
R2
R1
11
74
R2
CO2
R1
R2
75
O
R2
O
11
66-88%
The utility of an electrochemically generated cyanomethyl anion/carbon dioxide system in affording high yields of carbamates 6
using various kinds of amines 4 and alkyl halides 32 was further
investigated by Inesi and co-workers (Scheme 82).172
R1
Scheme 81.
NH
HN
Scheme 77.
R1
2. CO2
3. TsCl
OR
R2N-COOEt
6
Scheme 80.
1. e
O
1. R2NH
R1
N
R2
NH
Scheme 78.
CH2CN/CO2
EtI
R1
R2
up to 96%
OEt
Scheme 82.
O
R1
NH + CO2
R2
[Bmim]BF4, e
EtI, up to 82%
R1
N
R2
OEt
Scheme 83.
Scheme 79.
30
R'
Ni(II) +
+ CO2
R'
R'
DMF, rt
(1 atm.)
75-100%
103
O + O
N
R
104
105
Scheme 84.
Lu and co-workers have reported175 a new and efcient electrochemical synthesis of carbamates 6 through the electrochemical
incorporation of carbon dioxide into amines 4 catalysed by an
electrogenerated Ni complex [Ni(bipy)3Cl2] using tetra-ethylammonium bromide (Scheme 85).
R1
R
RuCl2{P(OEt)3}4
+ HN
79
NH + CO2
R2
EtI, up to 82%
OEt
R2
Scheme 85.
NH + R3X + K2CO3
1- 4 h,72-94%
32
R1
R3
R2
6
Scheme 86.
Baker and co-workers have reported177 a solvent-free ruthenium-catalysed synthesis of vinyl carbamates 83 through the reaction of phenylacetylene 79 with diethylamine 4 using
supericritical CO2 (Scheme 87). They have also studied the effect of
temperature on the catalytic activity of Ru complexes and found
that the best yields of vinyl carbamates were obtained at 120 C.
O
R1
+ CO2 + HN
Ph
79
RuCl3.xH2O
R2
R1
N
R2
3 h, 60-120oC
Ph
100%
83 (E and Z)
Scheme 87.
84
R3
NH2
R3
R3
R1
R2
scCO2, CuI
106
60oC, 12-24 h
R1 = alkyl, aryl, H
R2 = H
88-96%
O
R1
Scheme 88.
107
R1
N
R2
31-68%
83 (Z)
Scheme 89.
R1
Ni(bipy)3Cl2
scCO2, 15 h, 80oC
R2
O
R1
Ikariya and co-workers have also reported180 the synthesis of 5vinyl-1,3-oxazolidin-2-ones 109 through the carboxylative transformation of 2,3-allenic amines 108 and CO2 promoted by palladium catalysts under supercritical conditions (Scheme 90).
R1
Pd(OAc)2
NH
R2
R1
scCO2, 50oC, 15 h
up to 65%
108
R2
109
Scheme 90.
2RNH2 + CO2
4
OMe
45 + O
+ MeOH
O
OMe
(eq. 1)
RNH-COONH3R
45 OMe
(eq. 2)
NHR
111
110
OMe
111
+
NH2R
C
6
31
CO2 (eq. 3)
Scheme 91.
O
O
N
R1
N
112
Et3N, rt
+ HN
O
R1
N
N
5-10 h, 50-90%
R2
R2
113
Scheme 92.
R1
+ HN
N
O
OR
53-98%
R2
R1
rt, 0oC
R2
OR
114
Scheme 93.
O
O
O
O
114
OH
+ N3
N
O
115
116
69-80%
117
O
O
O
O
N
H
118
Scheme 94.
O
O
32
OTBS
TBSO
114
HO
119
O
O
120
O
O
O
H
Et3N, CH2Cl2
121
rt, 3 h
65-89%
NH2
Ph
OTBS
O
H
Ph
N
H
O
122
Scheme 95.
O
C
RO
O
CAL
+
O
123
H2N
124
P-acid
ArNH2 +
20-72 h, 38-45% RO
up to 98% ee
N
H
RO
OR
15-76 h, up to 98%
Scheme 96.
Scheme 98.
azides with trimethylphosphine 133 followed by the addition of 2(tert-butoxycarbonyloxyamino)-2-phenyl acetonitrile 134 to 135 at
20 C (Scheme 99).
Chandrasekhar and co-workers have reported194 an excellent
one-pot method for the synthesis of carbamates 6 through the
reaction of azides or Cbz-protected amines with di-tert-butyl
dicarbonate (Boc)2O 136 using an inexpensive and safe hydride
source, i.e., polymethylhydrosiloxane (PMHS) under PdeC catalysis
(Scheme 100).
The lipase enzyme has also been used as a catalyst in the synthesis of chiral carbamates195 138, starting from racemic amines 4
and alkylvinyl carbonates 137 (Scheme 101).
Leunaire and co-workers have reported196 an efcient synthesis
of carbamates 6 through the reaction of amines 4 with DMC 110
catalysed by g-Al2O3 (Scheme 102).
RN3
133
Me3P
O
O
Ph
N
CN
C
O
135
134
30oC, 128a
5oC, 128b
HO
RHN
HO
80-100%
128
130
Scheme 97.
HO
O
O
RHN
131a, 80%
131 131b, 52%
OBut
N
H
CAL, THF
127
5 h, 87-100%
Scheme 99.
126
HO
-20oC, rt
+ RN=PMe3
OBut
O
O
HO
OR
110, R = Me
132, R = Ph
125
HO
ArHN
129
129a, 70%
129b, 75%
33
Selva and workers have reported199 an efcient synthesis of carbamates 6 from primary aliphatic amines 4 with dialkyl carbonates
(R1Me, 110; R1Ph, 139) in supercritical CO2 (Scheme 105).
Scheme 105.
Scheme 100.
Scheme 101.
Scheme 102.
Scheme 106.
Scheme 103.
Carloni and co-workers have reported198 synthesis of carbamates 6 through the reaction of diethyl carbonate 139 with a variety of amines 4 using a heterogeneous catalyst-a hybrid organic/
inorganic material prepared by anchoring TBD to MCM-41 silica
(Scheme 104).
Scheme 107.
Scheme 104.
study were tert-butyl phenyl carbonate (141), benzyl phenyl carbonate (142) and allyl phenyl carbonate (143), which introduces the
Boc, Cbz and Alloc protecting groups.
Curini and workers have reported202 that ytterbium triate,
Yb(OTf)3, can be efciently used for the preparation of carbamates
34
Scheme 113.
Scheme 108.
Deng and co-workers have reported203 the synthesis of carbamates 6 through the reaction of primary and secondary aliphatic
amines 4 with DMC 110 using ionic liquids (Scheme 109).
Scheme 114.
Scheme 109.
Distaso and Quaranta have also reported209 the carbomethylating reactivity of methyl phenyl carbonate 153 towards aromatic
amines 4 in the presence of a group III metal (Sc, La) triate catalyst
under mild conditions to afford the corresponding carbamates 6 in
high yields (Scheme 115). They have optimised the effect of the
various catalysts at different temperatures, times and molar ratios
of amines on the yields of the carbamates. Sc(OTf)3 is more effective
than the La salt.
Scheme 110.
Scheme 115.
Scheme 111.
Chaudhari and co-workers have reported the synthesis of carbamates206 6 through the reaction of various organic carbonates
(RMe, 110; RPh, 132; REt, 139) with various amines 4, using
various catalysts (Scheme 112). Out of the several catalysts used, din-butyltin oxide was found to be the best in affording good yields of
the carbamates.
Scheme 116.
Later, Selva and co-workers have reported211 a high-yielding, onepot synthesis of methyl carbamates 6 from primary aliphatic amines
4 and dimethyl carbonate (110) using supercritical CO2 (Scheme 117).
The pressure of CO2 largely inuences both the reaction conversion
and the selectivity towards urethanes. Generally, conversion goes
through a maximum (70e80%) in the mid-range (40 bar) and drops at
lower and higher pressures, whereas selectivity is continuously improved (from 50 up to 90%) by an increase of pressure.
Scheme 112.
Scheme 117.
35
Deng and co-workers have reported212 the synthesis of carbamates 6 and dicarbamates 156 through the reaction of variety of
aliphatic amines 4 and bis-amines 155 with dimethyl carbonate 110
catalysed by acid-functionalised ionic liquids (Scheme 118). They
found that eSO3H functionalised ionic liquids were the most effective among the applied ionic liquids.
Scheme 122.
Scheme 118.
Scheme 123.
Scheme 119.
Scheme 124.
Recently, Sureshbabu and Hemantha have reported219 the synthesis of dipeptidyl carbamates 162 through the reaction of an
amino acid 161 with their synthesised F-moc aminoalkyl pentauorophenyl carbonate 160. They have further explored the utility
of 160 in the synthesis of oligopeptidyl carbamates using a variety
of amino acids (Scheme 125).
Scheme 120.
The use of DMC (110) in the synthesis of methyl phenyl carbamates 6 using aromatic amines and an ordered AISBA-15 catalyst
was recently reported by Halligudi and co-workers (Scheme 121).215
Scheme 125.
Scheme 126.
36
Scheme 127.
Scheme 130.
Scheme 131.
Iwasaki and co-workers have reported223 the synthesis of hydroxy carbamates 6a and 6b from cyclic ve-membered carbonates
167 and primary amines 4 at room temperature (Scheme 129).
Scheme 132.
Scheme 129.
Scheme 133.
conditions avoid the use of elemental bromine or heavy metal reagents, such as Pb(OAc)4, AgOAc and Hg(OAc)2, while taking advantage of the commercial availability of PhI(OAc)2.
Later, Huang and Keillor have reported231 synthesis of methyl
carbamates 6 via a modied Hoffmann rearrangement. They have
treated a series of p-substituted aromatic and primary aliphatic
carboxamides 173 with NBS and NaOMe in methanol heated to
reux for 10 min for the conversion of the carboxamides into their
corresponding primary amino methyl carbamates 6 in nearly
quantitative yields (Scheme 134). The mild oxidative conditions of
this modied Hoffmann rearrangement are shown to be particularly useful for the preparation of p-substituted anilines.
37
Hiegel and Hogenauer have reported235 a base-catalysed synthesis of N-substituted carbamates 6 through the rearrangement of
N-chloroamides (Scheme 138). These N-chloroamides were obtained by the chlorination of amides 173 using trichloroisocyanuric
acid (TCICA).
Scheme 138.
They have further elaborated232 the synthesis of methyl carbamates 6 through the involvement of a Hoffmann rearrangement
using NBS and DBU in methanol (Scheme 135). This method has
been widely used for the conversion of alkyl and aryl carboxamides
173 into their corresponding methyl carbamates 6 in excellent
yields under extremely mild conditions.
Scheme 139.
Gogoi and Konwar have reported237 a synthesis of methyl carbamates 6 through a modication of the Hoffmann rearrangement.
Thus, a series of methyl carbamates 6 were synthesized in good-toexcellent yields using NaOCl as an oxidant in the presence of KF/
Al2O3/MeOH under reux conditions (Scheme 140).
Scheme 135.
The synthesis of N-tert-butoxy carbamates 6 from primary carboxamides 173 using a copper(II) reagent (prepared from copper(II)
bromide and lithium tert-butoxide, i.e., CuBr2eLiOtBu), affording
good-to high-yields, has been reported by Yamaguchi and coworkers (Scheme 136).233
Scheme 140.
Scheme 136.
Later, Matsumara and co-workers have reported234 the electrochemical synthesis of carbamates 6 from primary carboxamides
173. The process has been referred to as an electrochemically induced (EI) Hoffmann rearrangement, which was developed using
new solvent systems containing a variety of alcohols 5, the reaction
proceeding under mild conditions (neutral). An epoxy functional
group in the amide and alcohol remains intact during the electrolysis (Scheme 137).
Scheme 137.
Scheme 141.
38
Scheme 142.
Scheme 146.
Scheme 143.
Scheme 147.
Recently, Papot and co-workers have reported an efcient synthesis of carbamates 6 through the reaction of a hydroxamic acid
179 with an alcohol 5 promoted by 2,4,6-trichloro-1,3,5-triazine
180 (cyanuric chloride; TCT) in the presence of an excess of Nmethyl morpholine (NMM) through Lossen a rearrangement reaction (Scheme 148).249
Scheme 144.
Scheme 148.
Scheme 149.
Scheme 145.
39
Scheme 150.
Scheme 154.
Scheme 155.
Scheme 151.
Scheme 156.
Scheme 152.
3.8.3. Carbamates synthesis using Burgess reagent. The Burgess reagent257 185 is prepared from a reaction of an alcohol 5 with
chlorosulfonyl isocyanate 183 and triethylamine 184 (Scheme 153)
and has been shown to be efcient for the stereospecic cisdehydration of secondary and tert-alcohols to provide olens. Primary alcohols do not undergo elimination, due to a competing (and
predominant) displacement reaction to form the corresponding
methyl carbamates. Several kinds of alcohols have been used, in
order to obtain a more efcient Burgess reagent, which could afford
carbamates in high yields. In recent years, researchers have directed their efforts to synthesising carbamates through the Burgess
reagent.
Scheme 157.
Scheme 153.
40
Scheme 158.
Scheme 163.
Scheme 164.
Scheme 159.
Scheme 165.
Scheme 160.
Scheme 161.
Scheme 166.
Scheme 167.
Scheme 162.
Recently, Nair and co-workers have reported the synthesis of Nacyl carbamates 203 through the reaction of substituted aldehydes
200 with dialkyl azodicarboxylates 201 and triphenylphosphine
202 (Scheme 168).272
41
Scheme 169.
Scheme 170.
4. Conclusions
This review gives a comprehensive survey regarding the synthesis of organic carbamates through the various starting materials
from the beginning to the most recent reports (covering the literature to December 2010). Organic carbamates have clearly been
demonstrated to be extremely useful and stable reagents, exhibiting
unique physical, chemical and biological properties. Furthermore, in
organic synthesis, organic carbamates have been shown to be
powerful instruments serving mainly as protecting groups for
amines, as well as synthons for several other functional-group
manipulations. Organic carbamates have become excellent templates for the formation of CeC and carboneheteroatom bonds.
Organic carbamates have also been utilised in the introduction of
oxygen moieties as well as in the activation of various functional
groups, which allows for a plethora of other applications. Organic
carbamates have frequently been used as synthons for the synthesis
of various kinds of structurally diverse synthetic intermediates,
which have broad applications in drug discovery synthesis. In recent
years, it has been realised by various researchers that the introduction of a carbamate functionality into various biologically
active synthetic/natural/semisynthetic molecules signicantly increases their biological activities. In addition, organic carbamates
have made a great impact in the elds of polymer science, biology
and medicine. Organic carbamates have also been utilised in industry and have thus made their way into everyday life. Their wide
1. (a) Adams, P.; Baron, F. A. Chem. Rev. 1965, 65, 567; (b) Carley, A. F.; Davies, P.
R.; Roberts, M. W. J. Chem. Soc., Chem. Commun. 1989, 677; (c) George, M.;
Weiss, R. G. J. Am. Chem. Soc. 2001, 123, 10393; (d) George, M.; Weiss, R. G.
Langmuir 2002, 18, 7124; (e) George, M.; Weiss, R. G. Langmuir 2003, 19, 1017;
(f) Carretti, E.; Dei, L.; Baglioni, P.; Weiss, R. G. J. Am. Chem. Soc. 2003, 125, 5121.
2. (a) Satchell, D. P. N.; Satchell, R. S. Chem. Soc. Rev. 1975, 4, 231; (b) Snieckus, V.
Chem. Rev. 1990, 90, 879; (c) Jessop, P. G.; Ikariya, T.; Noyori, R. Chem. Rev. 1995,
95, 259; (d) Tafesh, A. M.; Weiguny, J. Chem. Rev. 1996, 96, 2035; (e) Cleland,
W. W.; Andrews, T. J.; Gutteridge, S.; Hartman, F. C.; Lorimer, G. H. Chem. Rev.
1998, 98, 549; (f) Tanaka, F. Chem. Rev. 2002, 102, 4885.
3. (a) Yoshida, M.; Ohshima, M.; Toda, T. Heterocycles 1993, 35, 623; (b) Ager, A.
J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996, 96, 835; (c) Arya, P.; Qin, H. Tetrahedron 2000, 56, 917; (d) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33,
325.
4. (a) Inoue, S.; Yokoo, Y. Bull. Chem. Soc. Jpn. 1972, 45, 3651; (b) Wang, Y.;
Goekjian, P. G.; Ryckman, D. M.; Kishi, Y. J. Org. Chem. 1988, 53, 4153; (c) Boyle,
P. H.; Convery, M. A.; Davis, A. P.; Hosken, G. D.; Murray, B. A. J. Chem. Soc.,
Chem. Commun. 1992, 239; (d) Ragaini, F.; Cenini, S.; Demartin, F. J. Chem. Soc.,
Chem. Commun. 1992, 1467; (e) Jaitner, P.; Rieker, C.; Wurst, K. J. Chem. Soc.,
Chem. Commun. 1997, 1245; (f) Aoki, S.; Kawatani, H.; Goto, T.; Kimura, E.;
Shiro, M. J. Am. Chem. Soc. 2001, 123, 1123.
5. (a) Ray, S.; Chaturvedi, D. Drugs Future 2004, 29, 343; (b) Ray, S.; Pathak, S. R.;
Chaturvedi, D. Drugs Future 2005, 30, 161; (c) Shaw, S. J. Mini-Rev. Med. Chem.
2008, 8, 276; (d) Hutchinson, D. K. Curr. Top. Med. Chem. 2003, 3, 1021; (e)
Asaka, T.; Manaka, A.; Sugiyama, H. Curr. Top. Med. Chem. 2003, 3, 961; (f)
Miller, K.; Neilan, B.; Sze, D. M. Y. Recent Pat. AntiCancer Drug Discov. 2008, 3,
14.
6. (a) The Pesticidal Manual, 10th ed.; Thomlin. C. D. S. Ed.; Crop. Protection
Publication; Farnham, UK, 1994. (b) Goto, T.; Ito, Y.; Yamada, S.; Matsumoto,
H.; Ok, H.; Nagase, H. Anal. Chim. Acta 2006, 555, 225; (c) Batman, P. N.
Medicine 2003, 69; (d) Ma, J.; Lu, N.; Qin, W.; Xu, R.; Wang, Y.; Chen, X. Ecotoxicol. Environ. Saf. 2006, 63, 268.
7. (a) Wills, A. J.; Ghosh, Y. K.; Balasubramanian, S. J. Org. Chem. 2002, 67, 6646;
(b) Han, C.; Shen, R.; Su, S.; Porco, J. A. Org. Lett. 2004, 6, 27; (c) Smith, A. B.;
Freez, B. S.; LaMarche, M. J.; Hirose, T.; Brouard, I.; Rucker, R. V.; Xian, M.;
Sundermann, K. F.; Shaw, S. J.; Burlingame, M. A.; Horwitz, S. B.; Myles, D. C.
Org. Lett. 2005, 7, 311; (d) Dangereld, E. M.; Timmer, M. S. M.; Stocker, B. L.
Org. Lett. 2009, 11, 535.
8. (a) Greene, T. W.; Wuts, P. G. M. Protective Group in Organic Synthesis, 4th ed.;
John: New York, NY, 2007; (b) Kociensiki, P. J. Protective Groups, 3rd ed.;
Thieme: Stuttgart, 2003.
9. (a) Mayer, J. P.; Lewis, G. S.; Curtius, M. J.; Zhang, J. Tetrahedron Lett. 1997, 38,
8445; (b) Buchstaller, H. P. Tetrahedron 1998, 54, 3465; (c) Holte, P. T.; Thijs, L.;
Zwanenburg, B. Tetrahedron Lett. 1998, 39, 7404.
10. (a) Alaxander, J. P.; Cravatt, B. F. Chem. Biol. 2005, 12, 1179; (b) Chang, P. A.; Wu,
Y. J.; Li, W.; Leng, X. F. Chem-Biol. Interact. 2006, 159, 65; (c) Tully, D. C.; Liu, H.;
Chatterjee, A. K.; Alper, P. B.; Williams, J. A.; Roberts, M. J.; Mutnick, D.;
Woodmansee, D. H.; Hollenbeck, T.; Gordon, P.; Chang, J.; Tutland, T.; Tumanut, C.; Li, J.; Harris, J. L.; Karenwasky, D. S. Bioorg. Med. Chem. Lett. 2006, 16,
5107.
11. (a) Chedid, R. B.; Brummer, M.; Wibbeling, B.; Fohlich, R.; Hoppe, D. Angew.
Chem., Int. Ed. 2007, 46, 3131; (b) Becker, J.; Grimme, S.; Frohlich, R.; Hoppe, D.
Angew. Chem., Int. Ed. 2007, 46, 1645; (c) Qin, H.; Yamagiva, N.; Matsunaga, S.;
Shibasaki, M. Angew. Chem., Int. Ed. 2007, 46, 409; (d) Han, X.; Widenhoefer, R.
A. Angew. Chem., Int. Ed. 2006, 45, 1747; (e) Nicolaou, K. C.; Mathison, J. N.
Angew. Chem., Int. Ed. 2005, 44, 5992.
12. (a) Rahmanthullan, S. M.; Tidwell, R. R.; Jones, S. K.; Hall, J. E.; Boykin, D. W.
Eur. J. Med. Chem. 2008, 43, 174.
13. (a) Chaturvedi, D. Chapter 2: synthesis of organic carbamates through various
approaches. Ph.D. Thesis, Agra University, India, 2003; (b) Takaoka, K.; Tatsu,
Y.; Yumoto, N.; Nakajima, T.; Shimamoto, K. Bioorg. Med. Chem. 2004, 12, 3687;
(c) Borrel, C.; Thoret, S.; Cachet, X.; Guenard, D.; Tillequin, F.; Koch, M.; Michel,
S. Bioorg. Med. Chem. 2005, 13, 3853; (d) Holas, T.; Vavrova, K.; Sima, M.;
Klimentova, J.; Hravalek, A. Bioorg. Med. Chem. 2006, 14, 7671.
42
14. (a) Giannessi, F.; Pessotto, P.; Tassoni, E.; Chiodi, P.; Conte, R.; Angeles, F. D.;
Uomo, N. D.; Catini, R.; Deias, R.; Tinti, M. O.; Carminate, P.; Ardnini, A. J. Med.
Chem. 2003, 46, 303; (b) Ouellet, R.; Rousseau, J.; Brasseur, N.; Lier, J. E.;
Doksic, M.; Westera, G. J. Med. Chem. 1984, 27, 509; (c) Li, Q. Y.; Zu, Y. G.; Shi, R.
Z.; Yao, L. P. Curr. Med. Chem. 2006, 13, 2021; (d) Wu, X.; Ojima, I. Curr. Med.
Chem. 2004, 11, 429; (e) Wu, Y. J.; Su, W. J. Curr. Med. Chem. 2001, 8, 1727; (f)
Reiss, A. B.; Vagell, M. E. Curr. Med. Chem. 2006, 13, 3227; (g) Sharma, V.; Hupp,
C. D.; Tepe, J. J. Curr. Med. Chem. 2007, 14, 1061; (h) Shao, Y.; Ding, H.; Tang, W.;
Lou, L.; Hu, L. Bioorg. Med. Chem. 2007, 15, 5061; (i) Ishihara, Y.; Goto, G.;
Miyamoto, M. Curr. Med. Chem. 2000, 7, 341; (j) Palomo, C.; Aizpurua, J. M.;
Ganboa, I.; Oiarbiode, M. Curr. Med. Chem. 2004, 11, 1837; (k) Zega, A. Curr.
Med. Chem. 2005, 12, 589; (l) Vinsova, J.; Imramvosky, A.; Jampilek, J.; Monreal,
J. F.; Dolezal, M. Anti-Infect. Agents Med. Chem. 2008, 7, 12.
15. Shaw, K. F.; Sundermann, K. F.; Burlingame, M. A.; Zhang, D.; Petryka, J.; Myles,
D. C. Bioorg. Med. Chem. Lett. 2006, 16, 1961.
16. Wang, Y.; Li, L.; Tian, Z.; Jiang, W.; Larrick, J. W. Bioorg. Med. Chem. 2006, 14,
7854.
17. Chen, S. W.; Wang, Y. H.; Jin, Y.; Tian, X.; Zheng, Y. T.; Luo, D. Q.; Tu, Y. Q. Bioorg.
Med. Chem. Lett. 2007, 17, 2091.
18. Andez, J. C. Beilstein J. Org. Chem. 2009, 5 avaliable online. (mdoi:10.3762/bjoc.
5.33).
19. Oves, D.; Fernandez, S.; Verlinden, L.; Bouillon, R.; Verstuyf, A.; Ferrero, M.;
Gotor, V. Bioorg. Med. Chem. 2006, 14, 7512.
20. Tian, Z. Q.; Liu, Y.; Zhang, D.; Wang, Z.; Dong, S. D.; Carreras, C. W.; Zhou, Y.;
Rastelli, G.; Santi, D. V.; Myles, D. C. Bioorg. Med. Chem. 2004, 12, 5317.
21. Fardis, M.; Pyun, H. J.; Tario, J.; Jin, H.; Kim, C. U.; Ruckman, J.; Lin, Y.; Greenc,
L.; Hicke, B. Bioorg. Med. Chem. 2003, 11, 5051.
22. Santos, R. C.; Salvador, J. A. R.; Marin, S.; Cascante, M. Bioorg. Med. Chem. 2009,
17, 6241.
23. Sedlak, M.; Dravina, P.; Bilkova, E.; Simunek, P.; Buchta, V. Bioorg. Med. Chem.
Lett. 2008, 18, 2952.
24. Yoshizawa, H.; Kubota, T.; Itani, H.; Minami, K.; Miwa, H.; Nishitani, H. Bioorg.
Med. Chem. 2004, 12, 4221.
25. Jeffrey, S. C.; Nguyen, M. T.; Andreyka, J. B.; Meyer, D. L.; Doronina, S. O.;
Senter, P. D. Bioorg. Med. Chem. Lett. 2006, 16, 358.
26. Wagner, R.; Mollison, K. W.; Liu, L.; Henry, C. L.; Rosenberg, T. A.; Bamaung, N.;
Tu, N.; Wiedeman, P. E.; Or, Y.; Luly, J. R.; Lane, B. C.; Trevillyan, J.; Chen, Y. W.;
Fey, T.; Hsieh, G.; Marsh, K.; Nuss, M.; Jacobson, P. B.; Wilcox, D.; Carlson, R. P.;
Carter, G. W.; Djuric, S. W. Bioorg. Med. Chem. Lett. 2005, 15, 5340.
27. Shi, S.; Zhu, S.; Gerritz, S. W.; Esposito, K.; Padmanabha, R.; Li, W.; Herbst, J. J.;
Wong, H.; Shu, Y. Z.; Lamc, K. S.; Soaa, M. J. Bioorg. Med. Chem. Lett. 2005, 15,
4151.
28. Mazurov, A.; Klucik, J.; Miao, L.; Phillips, T. Y.; Seamans, A.; Schmitt, J. D.;
Hauser, T. A.; Johnson, R. T.; Miller, C. Bioorg. Med. Chem. Lett. 2005, 15, 2073.
29. Yu, Q. S.; Pei, X. F.; Holloway, H. W.; Greig, N. H. J. Med. Chem. 1997, 40, 2895.
30. Shen, G.; Yu, X. M.; Blagg, B. S. J. Bioorg. Med. Chem. Lett. 2004, 14, 5903.
31. Sharma, U.; Marquis, J. C.; Dinaut, A. N.; Hillier, S. M.; Fedeles, B.; Rye, P. T.;
Essigmann, J. M.; Croy, R. G. Bioorg. Med. Chem. Lett. 2004, 14, 3829.
32. Lee, Y.; Koo, H.; Lim, Y. B.; Lee, Y.; Moa, H.; Park, H. J. Bioorg. Med. Chem. Lett.
2004, 14, 2637.
33. Taguchi, M.; Goda, K.; Sugimoto, K.; Akama, T.; Yamamoto, K.; Suzuki, T.;
Tomishima, Y.; Nishiguchi, M.; Arai, K.; Takahashi, K.; Kobori, T. Bioorg. Med.
Chem. Lett. 2003, 13, 3681.
34. McComas, C.; Crowley, B. M.; Hwang, I.; Boger, D. L. Bioorg. Med. Chem. Lett.
2003, 13, 2933.
35. Peng, X.; Knapp, B. I.; Bidlack, J. M.; Neumeyer, J. N. Bioorg. Med. Chem. Lett.
2007, 17, 1508.
36. Combrink, K. D.; Denton, D. A.; Harran, S.; Ma, Z.; Chapo, K.; Yan, D.; Bonventre, E.; Roche, E. D.; Doyle, T. B.; Robertson, G. T.; Lynch, A. S. Bioorg. Med.
Chem. Lett. 2007, 17, 522.
37. Bergeron, R. J.; Bharti, N.; Singh, S.; McManis, J. S.; Wiegand, J.; Green, L. G. J.
Med. Chem. 2009, 52, 3801.
, B.; Kristofkov
snsky
, M.; Dur
38. Slavkova
a, Z.; Chodounsk
a, H.; Bude
an, F. J.;
Veleiro, A. S.; Burton, G.; Kasal, A. J. Med. Chem. 2009, 52, 2119.
39. Chackalamannil, S.; Wang, Y.; Greenlee, W. J.; Hu, Z.; Xia, H.; Ahn, H. S.;
Boykow, G.; Hsieh, Y.; Palamanda, J.; Agans-Fantuzzi, J.; Kurowski, S.; Graziano, M.; Chintala, M. J. Med. Chem. 2008, 51, 3061.
40. Schweitzer, D.; Zhu, J.; Jarori, G.; Tanaka, J.; Higa, T.; Davissona, V. J.; Helquist,
P. Bioorg. Med. Chem. 2007, 15, 3208.
cor, A.; Monse, B.; Martin, M. T.; Chiaroni, A.; Thoret, S.; Gue
nard, D.;
41. De
ritte, F.; Baudoin, O. Bioorg. Med. Chem. 2006, 14, 2314.
Gue
42. Jaracz, S.; Chen, J.; Kuznetsova, L. V.; Ojima, I. Bioorg. Med. Chem. 2005, 13,
5043.
43. Billich, A.; Vyplel, H.; Grassberger, M.; Schmook, F. P.; Steck, A.; Stuetz, A.
Bioorg. Med. Chem. 2005, 13, 3157.
44. Kupchinsky, S.; Centioni, S.; Howard, T.; Trzupek, J.; Roller, S.; Carnahan, V.;
Townes, H.; Purnell, B.; Price, C.; Handl, H.; Summerville, K.; Johnson, K.; Toth,
J.; Hudson, S.; Kiakos, K.; Hartley, J. A.; Lee, M. Bioorg. Med. Chem. 2004, 12,
6221.
45. Burkhart, D. J.; Barthel, B. L.; Post, G. C.; Kalet, B. T.; Nae, J. W.; Shoemaker, R.
K.; Koch, T. H. J. Med. Chem. 2006, 49, 7002.
46. (a) Arico-Muendel, C. C.; Benjamin, D. R.; Caiazzo, T. M.; Centrella, P. A.;
Contonio, B. D.; Cook, C. M.; Doyle, E. G.; Hannig, G.; Labenski, M. T.; Searle, L.
L.; Lind, K.; Morgan, B. A.; Olson, G.; Paradise, C. L.; Self, C.; Skinner, S. R.;
Sluboski, B.; Svendsen, J. L.; Thompson, C. D.; Westlin, W.; White, K. F. J. Med.
Chem. 2009, 52, 8047; (b) Miyata, Y. Curr. Pharm. Des. 2009, 11, 5317; (c) Xu, H.;
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
Lv, M.; Tian, X. Curr. Med. Chem. 2009, 16, 327; (d) Tripathi, R.; Angeles, T. S.;
Yang, S. X.; Mallamo, J. P. Bioorg. Med. Chem. Lett. 2008, 18, 3551.
(a) Takashima, H. Curr. Top. Med. Chem. 2003, 3, 991; (b) Yan, S.; Miller, M. J.;
Wencewicz, T. A.; Mollmann, U. MedChemComm 2010, 1, 145.
Bova, F.; Ettari, R.; Micale, N.; Carnovale, C.; Schirmiester, T.; Gelhouse, C.;
Leippe, M.; Grasso, S.; Zappala, M. Bioorg. Med. Chem. 2010, 18, 4928.
Mizutani, T.; Ishikawa, S.; Nagase, T.; Takahashi, H.; Fujimura, T.; Sasaki, T.;
Nagumo, A.; Shimamura, K.; Miyamoto, Y.; Kitazawa, H.; Kanesaka, M.;
Yoshimoto, R.; Aragane, K.; Tokita, S.; Sato, N. J. Med. Chem. 2009, 52, 7289.
Yekini, I.; Hammoudi, F.; Martin-Nizard, F.; Yous, S.; Lebegue, N.; Berthelot, P.;
Carato, P. Bioorg. Med. Chem. 2009, 17, 7823.
Ali, A.; Balkovec, J. M.; Greenlee, M.; Hammond, M. N.; Rouen, G.; Taylor, G.;
Einstein, M.; Ge, L.; Harris, G.; Kelly, T. M.; Mazur, P.; Pandit, S.; Santoro, J.;
Sitlani, A.; Wang, C.; Williamson, J.; Forrest, M. J.; Carballo-Janne, E.; Luell, S.;
Lowitz, K.; Visco, D. Bioorg. Med. Chem. 2008, 16, 7535.
Janin, Y. L. Bioorg. Med. Chem. 2007, 15, 2479.
Kern, J. C.; Terefenko, E. A.; Fensome, A.; Unwalla, R.; Wrobel, J.; Zhu, Y.; Cohen, J.; Winneker, R.; Zhang, Z.; Zhang, P. Bioorg. Med. Chem. Lett. 2007, 17, 189.
Franciskovich, J. B.; Masters, J. J.; Tinsley, J. M.; Craft, T. J.; Froelich, L. L.; Gifford-Moore, D. S.; Klimkowski, V. J.; Smallwood, J. K.; Smith, G. F.; Smith, T.;
Towner, R. R.; Weir, L. C.; Wiley, M. R. Bioorg. Med. Chem. Lett. 2005, 15, 4838.
Ohta, K.; Ogawa, T.; Suzuki, T.; Ohta, S.; Endo, Y. Bioorg. Med. Chem. 2009, 17,
7958.
Kuznetsova, L.; Chen, J.; Sun, L.; Wu, X.; Pepe, A.; Veith, J. M.; Pera, P.; Bernacki,
R. J.; Ojima, I. Bioorg. Med. Chem. Lett. 2006, 16, 974.
(a) Babad, H.; Zeiler, A. G. Chem. Rev. 1973, 73, 75; (b) Chaturvedi, D.; Mishra,
N.; Mishra, V. Curr. Org. Synth. 2007, 4, 308.
(a) Kurita, K.; Matsumara, T.; Iwakura, Y. J. Org. Chem. 1976, 41, 2076; (b) Kurita,
K.; Matsumara, T.; Iwakura, Y. Org. Synth. 1980, 59, 195; (c) Kurita, K.; Matsumara, T.; Iwakura, Y. J. Org. Chem. 1985, 50, 715.
Cotarka, L.; Delgu, P.; Mardelli, A.; Sunjuc, V. Synthesis 1996, 553.
Pasguato, L.; Modena, G.; Cotarca, L.; Delgu, P.; Mantovami, S. J. Org. Chem.
2000, 65, 8224.
Raucher, S.; Jones, D. S. Synth. Commun. 1985, 15, 1025.
(a) Corey, E. J.; Bock, M. G.; Korikowski, A. P.; Ramarao, A. V.; Floyd, R. D.;
Lipshutz, B. Tetrahedron Lett. 1978, 19, 1051; (b) Windholz, T. B.; Johnston, D. B.
R. Tetrahedron Lett. 1967, 8, 2555; (c) Carson, J. F. Synthesis 1981, 268; (d) Ariza,
X.; Urpi, F.; Viladomat, C.; Vilarrassa, J. Tetrahedron Lett. 1998, 39, 9101; (e)
Ariza, X.; Urpi, F.; Vilarrasa, J. Tetrahedron Lett. 1999, 40, 7515.
(a) Yadav, J. S.; Reddy, G. S.; Reddy, M. M.; Meshram, H. M. Tetrahedron Lett.
1998, 39, 3259; (b) Yadav, J. S.; Reddy, B. V. S.; Reddy, G. S. K. K. New J. Chem.
2000, 24, 571.
Chandrasekhar, S.; Narsihmula, C.; Jagadeshwar, V. Synlett 2002, 771.
Pandey, R. K.; Dagade, S. P.; Dongare, M. K.; Kumar, P. Synth. Commun. 2003,
33, 4019.
Mormeneo, D.; Llebaria, A.; Delgado, A. Tetrahedron Lett. 2004, 45, 6831.
Raje, V. P.; Bhat, R. P.; Samant, S. D. Tetrahedron Lett. 2005, 46, 835.
Kim, J. G.; Jung, D. O. Tetrahedron Lett. 2009, 50, 2688.
(a) Ozaki, S. Chem. Rev. 1972, 72, 457.
(a) Knolker, H. J.; Braxmeier, T. Tetrahedron Lett. 1996, 37, 5861; (b) Kocovsky, P.
Tetrahedron Lett. 1986, 27, 5521; (c) Azonlay, M.; Escriou, V.; Florent, J. C.;
Monneret, C. J. Carbohydr. Chem. 2001, 20, 841; (d) March, J. Advanced Organic
Chemistry, 4th ed.; Wiley: 1991; p 891.
(a) Versteegen, R. M.; Sijbesma, R. P.; Maijer, F. W. Angew. Chem., Int. Ed. 1999,
38, 2917; (b) Davis, A. G. J. Chem. Res. 2010, 34, 181.
Leeners, R. G. G.; Ruytenbeek, R.; Damen, E. W. P.; Scheeren, H. W. Synthesis
1996, 1309.
Duggan, M. E.; Imagire, J. S. Synthesis 1989, 131.
(a) Okuda, S. Japanese Patent, JP57158746, 1983; Chem. Abstr. 1983, 98,
144386b; (b) Okuda, S. Japanese Patent, JP 57158747, 1983; Chem. Abstr. 1983,
98, 160402j; (c) Yagii, T. U. S. Patent, 5,789,614, 1998; (d) Gerhard, L. D. European Patent, EP 19541384, 1997.
(a) Valli, V. L. K.; Alper, H. J. Org. Chem. 1995, 60, 257; (b) Butler, D. C. D.; Alper,
H. Chem. Commun. 1998, 2575.
Pirkle, W. H.; Hoekstra, M. S. J. Org. Chem. 1977, 42, 2781.
Chong, P. Y.; Janicki, S. Z.; Petillo, P. A. J. Org. Chem. 1998, 63, 8515.
Gastaldi, S.; Weinreb, S. M.; Stien, D. J. Org. Chem. 2000, 65, 3239.
Saylik, D.; Horvath, M. J.; Elmes, P. S.; Jackson, W. R. J. Org. Chem. 1999, 64,
3940.
Uriz, P.; Serra, M.; Salagre, P.; Castillon, S.; Claver, C.; Fernandez, E. Tetrahedron
Lett. 2002, 43, 1673.
Dai, Y.; Wang, Y.; Yao, J.; Wang, Q.; Liu, L.; Chu, W.; Wang, G. Catal. Lett. 2008,
123, 307.
Juarez, R.; Corma, A.; Garcia, H. Top. Catal. 2009, 52, 1688.
(a) Watanabe, Y.; Tsuji, Y.; Takeuchi, R. Bull. Chem. Soc. Jpn. 1984, 57, 3011; (b)
Watanabe, Y.; Tsuji, Y.; Takeuchi, R.; Suzuki, N. Bull. Chem. Soc. Jpn. 1983, 56,
3343; (c) Watanabe, Y.; Tsuji, Y.; Takeuchi, R.; Suzuki, N. Chem. Lett. 1982, 105.
Grabtree, R. H.; Davis, M. W.; Mellca, M. W.; Mehelic, J. M. Inorg. Chim. Acta
1983, 72, 223.
Alper, H.; Hashem, K. E. J. Chem. Soc. 1981, 103, 6514.
Cenini, S.; Crotti, C. Metal Promoted Selectivity in Organic Synthesis. Kluwer
Academic: The Netherlands, 1991.
Cenini, S.; Crotti, C.; Pizzoti, M.; Pota, F. J. Org. Chem. 1988, 53, 1243.
(a) Skoog, S. J.; Campbell, J. P.; Gladfelter, W. L. Organometallics 1994, 13, 4137;
(b) Sherlock, S. J.; Boyed, D. C.; Moasser, B.; Gladfelter, W. L. Inorg. Chem. 1991,
30, 3626; (c) Gargulack, J. D.; Berry, A. J.; Noirot, M. D.; Gladfelter, W. L. J. Am.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
137.
Chem. Soc. 1992, 114, 8933; (d) Gargulk, J. D.; Gladfelter, W. L. Inorg. Chem.
1994, 33, 253; (e) Gargulak, J. D.; Gladfelter, W. L. J. Am. Chem. Soc. 1994, 116,
3792.
(a) Ragaini, F.; Cenini, S.; Fumagalli, A.; Crotti, C. J. Organomet. Chem. 1992, 428,
401; (b) Liu, C.; Chang, C. J. Organomet. Chem. 1992, 428, 420; (c) Ragaini, F.;
Cenini, S.; Demartin, F. Organometallics 1994, 13, 1178.
(a) Braustien, P.; Bender, R.; Karvennal, J. Organometallics 1982, 1, 1236; (b)
Hardy, W. B.; Bennet, R. P. Tetrahedron Lett. 1967, 961; (c) Watanabe, Y.; Tsuji,
Y.; Suzuki, N. Chem. Lett. 1982, 105.
Gupta, S. P.; Chaudhary, R. V. J. Mol. Catal. A: Chem. 1984, 25, 197.
Allesio, E.; Mustrom, G. J. Organomet. Chem. 1985, 291, 117.
Bontempi, A.; Alessio, E.; Chanos, G.; Mestrom, G. J. Mol. Catal. A: Chem. 1987,
42, 67.
Izumi, Y.; Satoh, Y.; Koudoh, H.; Ube, K. J. Mol. Catal. A: Chem. 1992, 72, 37.
Cenini, S.; Pizzoti, M.; Crotti, C.; Porta, F.; Lamonica, G. J. Chem. Soc., Chem.
Commun. 1984, 1286.
Cenini, S.; Pizzoti, M.; Crotti, C.; Porta, F.; Lamonica, G. J. Mol. Catal. A: Chem.
1988, 49, 59.
(a) Grate, J. H.; Hamm, D. R.; Valentine, D. H. WO85/01285; (b) Grate, J. H.;
Hamm, D. R.; Valentine, D. H. U.S. Patent, 4,687,872, 1987.
(a) Valli, V. L. K.; Alper, H. J. Am. Chem. Soc. 1993, 115, 3778; (b) Chaudhary, B.
M.; Sharma, G. V. M.; Bharti, P. Angew. Chem., Int. Ed. Engl. 1989, 28, 465.
Porzelle, A.; Woodrow, M. D.; Tomkinson, N. C. O. Synlett 2009, 798.
Fukuoka, S.; Chono, M.; Kohno, M. J. Chem. Soc., Chem. Commun. 1984, 399.
Chow, Y.; Marciniak, B.; Misra, P. J. Org. Chem. 1984, 49, 1458.
Leung, T. W.; Domblk, B. D. J. Chem. Soc., Chem. Commun. 1992, 205.
Alper, H.; Hartstock, F. W. J. Chem. Soc., Chem. Commun. 1985, 1141.
Pri-Bar, I.; Schwartz, J. J. Org. Chem. 1995, 60, 8124.
Shi, F.; Deng, Y. Chem. Commun. 2001, 443.
Mizuno, T.; Takahashi, J.; Ogawa, A. Tetrahedron 2002, 58, 7805.
Wan, B.; Liao, S.; Yu, D. Appl. Catal., A 1999, 183, 81.
Shi, F.; Deng, Y.; Sima, T.; Yang, H. J. Catal. 2001, 203, 525.
Shi, F.; Deng, Y. J. Catal. 2002, 211, 548.
Shi, F.; Peng, J.; Deng, Y. J. Catal. 2003, 219, 372.
Li, G.; Chen, L.; Bao, J.; Li, T.; Mei, M. Appl. Catal., A 2008, 346, 134.
Zhang, X.; Jing, H.; Zhang, G. Synth. Commun. 2010, 40, 1614.
(a) Kondo, K.; Sonada, N.; Tsutsumi, S. Chem. Lett. 1972, 373; (b) Gomez-Para,
V.; Sanchez, F.; Torres, T. Synthesis 1985, 282; (c) Gomez-Para, V.; Sanchez, F.;
Torres, T. J. Chem. Soc., Perkin Trans. 1 1987, 695.
Gormans, M.; Ritter, H. Tetrahedron 1993, 49, 6965.
Butcher, K. J. Synlett 1994, 825.
(a) Carpino, L. A.; Gao, H. S.; Ti, G. S.; Seger, D. J. Org. Chem. 1989, 54, 588; (b)
Carpino, L. A.; Han, G. Y. J. Org. Chem. 1972, 37, 3404; (c) Schoen, I.; Kisfaludy, L.
Synthesis 1986, 303.
Inesi, A.; Mucciante, V.; Rosii, L. J. Org. Chem. 1998, 63, 1337.
(a) Chaturvedi, D.; Ray, S. Curr. Org. Chem. 2007, 11, 987; (b) Dell0 Amico, C. B.;
Calderazzo, F.; Labella, L.; Marchetti, F.; Pampaloni, G. Chem. Rev. 2003, 103,
3857.
(a) Shaikh, A. G.; Sivaram, S. Chem. Rev. 1996, 96, 951; (b) Parrish, J. P.; Salvatore, R. N.; Jung, K. W. Tetrahedron 2000, 56, 8207; (c) Sakakura, T.; Choi, J.
C.; Yashuda, H. Chem. Rev. 2007, 107, 2365; (d) Chaturvedi, D.; Mishra, N.;
Mishra, V. Tetrahedron Lett. 2007, 48, 5043; (e) Darensbourg, D. J. Chem. Rev.
2007, 107, 2388; (f) Sakakura, T.; Kohno, K. Chem. Commun. 2009, 1312.
(a) Xu, H.; Rudkevich, D. M. Chem.dEur. J. 2004, 10, 5432; (b) Hobbs, R.;
Thomas, N. R. Chem. Rev. 2007, 107, 2786; (c) Chaturvedi, D.; Mishra, N.;
Mishra, V. Synthesis 2008, 355; (d) Chaturvedi, D.; Mishra, N.; Mishra, V.
Monatsh. Chem. 2008, 139, 267; (e) Chaturvedi, D.; Chaturvedi, A. K.; Mishra,
N.; Mishra, V. Synth. Commun. 2008, 38, 4013; (f) Chaturvedi, D.; Chaturvedi,
A. K.; Mishra, N.; Mishra, V. J. Iran. Chem. Soc. 2009, 6, 510; (g) Chaturvedi, A.
K.; Chaturvedi, D.; Mishra, N.; Mishra, V. J. Iran. Chem. Soc. 2010, 7, 702; (h)
Chaturvedi, A. K.; Chaturvedi, D.; Mishra, N.; Mishra, V. J. Iran. Chem. Soc. 2011,
8, 396.
Wright, H. B.; Moore, M. B. J. Am. Chem. Soc. 1948, 70, 3865.
Yoshida, Y.; Inoue, S. Chem. Lett. 1977, 1375.
(a) Yoshida, Y.; Ishii, S.; Yamashita, T. Chem. Lett. 1984, 1571; (b) Yoshida, Y.;
Ishii, S.; Watanabe, M.; Yamashita, T. Bull. Chem. Soc. Jpn. 1989, 62, 1534.
Ishii, S.; Nakayama, H.; Yoshida, Y.; Yamashita, T. Bull. Chem. Soc. Jpn. 1989, 62,
455.
Yoshida, Y.; Inoue, S. Chem. Lett. 1978, 139.
Yoshida, Y.; Inoue, S. Bull. Chem. Soc. Jpn. 1978, 51, 559.
Asano, T.; Saito, N.; Ito, S.; Hatakeda, K.; Toda, T. Chem. Lett. 1978, 311.
Yoshida, Y.; Inoue, S. J. Chem. Soc., Perkin Trans. 1 1979, 3146.
Christ, E.; Kojima, F.; Aida, T.; Inoue, S. J. Am. Chem. Soc. 1986, 108, 391.
Toda, T. Chem. Lett. 1977, 957.
Saito, N.; Hatakeda, K.; Ito, S.; Asano, T.; Toda, T. Bull. Chem. Soc. Jpn. 1986, 59,
1629.
Hori, Y.; Nagano, Y.; Nakao, J.; Fukuhara, T.; Taniguchi, H. Chem. Express 1986, 224.
Aresta, M.; Quaranta, E. Tetrahedron 1992, 48, 1515.
(a) McGhee, W. D.; Pan, Y.; Riley, D. P. Chem. Commun. 1996, 699; (b) McGhee,
W. D.; Riley, D. P.; Christ, K.; Pan, Y.; Parnas, B. J. Org. Chem. 1995, 60, 2820.
(a) McGhee, W. D.; Riley, D. P.; Christ, M. K. M. Organometallics 1992, 12, 1429;
(b) Aresta, M.; Quaranta, E. CHEMTECH 1997, 32.
Perez, E. R.; Silva, M. O.; Costa, V. C.; Filho, U. P. R.; Franco, D. W. Tetrahedron
Lett. 2002, 43, 4091.
Kubota, Y.; Kodaka, M.; Tomohiro, T.; Okuno, H. J. Chem. Soc., Perkin Trans. 1
1993, 5.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
43
44
200. Sumiyoshi, H.; Shimizu, T.; Katoh, M.; Baba, Y.; Sodeoka, M. Org. Lett. 2002, 4,
3923.
201. Pittelkow, M.; Lewinsky, R.; Christensen, J. B. Synthesis 2002, 2195.
202. Curini, M.; Epifano, F.; Malterse, F.; Rosate, O. Tetrahedron Lett. 2002, 43, 4895.
203. Sima, T.; Guo, S.; Shi, S.; Deng, Y. Tetrahedron Lett. 2002, 43, 8145.
204. Jung, Y. J.; Chang, Y. M.; Lee, J. H.; Yoon, C. M. Tetrahedron Lett. 2002, 43,
8735.
205. Chadrasekhar, S.; Babu, B. N.; Reddy, C. R. Tetrahedron Lett. 2003, 44, 2057.
206. Shivarkar, A. B.; Gupte, S. P.; Chaudhari, R. V. J. Mol. Catal. A: Chem. 2004, 223,
85.
207. Shen, Z. L.; Jiang, X. Z. Chin. Chem. Lett. 2004, 15, 889.
208. Distaso, M.; Quaranta, E. Tetrahedron 2004, 60, 1531.
209. Distaso, M.; Quaranta, E. J. Catal. 2004, 228, 36.
210. Simon, M.; Sunderlik, C.; Caproiu, M. T.; Neda, I.; Turozci, M. C.; Volpicelli, R.
Synth. Commun. 2005, 35, 1471.
211. Selva, M.; Tundo, P.; Perosa, A.; DallAcqua, F. J. Org. Chem. 2005, 70, 2771.
212. Zhou, H.; Shi, F.; Tian, X.; Zhang, Q.; Deng, Y. J. Mol. Catal. A: Chem. 2007, 271,
89.
213. (a) Gao, J. J.; Li, H. Q.; Zhang, Y. Chin. Chem. Lett. 2007, 18, 149; (b) Gao, J.; Li, H.;
Zhang, Y.; Zhang, Y. Green Chem. 2007, 9, 572.
214. Han, C.; Porco, J. A. Org. Lett. 2007, 9, 1517.
215. Lucas, N.; Amrute, A. P.; Palraj, K.; Shanvag, G. V.; Vinu, A.; Halligudi, S. B. J.
Mol. Catal A: Chem. 2008, 295, 29.
216. Yoshida, Y.; Komatsuzaki, Y.; Ihara, M. Org. Lett. 2008, 10, 2083.
217. Li, F.; Wang, Y.; Xue, W.; Zhao, X. J. Chem. Technol. Biotechnol. 2009, 84, 48.
218. Fu, X.; Zhang, Z.; Li, C.; Wang, L.; Ji, H.; Yang, Y.; Zhou, T.; Gao, G. Catal.
Commun. 2009, 10, 665.
219. Sureshbabu, V. V.; Hemantha, H. Synth. Commun. 2009, 39, 3555.
220. Kumar, K. S.; Iqbal, J.; Pal, M. Tetrahedron Lett. 2009, 50, 6244.
221. Karmakar, B.; Banerji, J. Tetrahedron Lett. 2010, 51, 3855.
222. Lumbroso, A.; Chevallier, F.; Beaudet, I.; Quintard, J. P.; Besson, T.; Grognec, E.
L. Tetrahedron 2009, 65, 9180.
223. Iwasaki, T.; Kihara, N.; Eudo, T. Bull. Chem. Soc. Jpn. 2000, 73, 713.
224. Tandel, S. K.; Rajappa, S.; Pansare, S. V. Tetrahedron 1993, 49, 7479.
225. Degani, I.; Fochi, R.; Magistris, C. Synthesis 2008, 2919.
226. Anbazhagan, M.; Reddy, T. I.; Rajappa, S. J. Chem. Soc., Perkin Trans. 1 1997,
1623.
227. Reddy, T. I.; Bhawal, B. M.; Rajappa, S. Tetrahedron Lett. 1992, 33, 2857.
228. (a) Kulkarni, C. H.; Naik, R. H.; Tandel, S. K.; Rajappa, S. Tetrahedron 1991, 47,
1249; (b) Deshpande, S. R.; Likhite, A. P.; Rajappa, S. Tetrahedron 1994, 50, 10367.
229. Wallis, E. W.; Lane, J. F. Org. React. 1946, 3, 267.
230. Moriarty, R. M.; Chany, C. J., II; Vaid, R. K.; Prakash, O.; Tulandher, S. M. J. Org.
Chem. 1993, 56, 2478.
231. Huang, X.; Keillor, J. W. Tetrahedron Lett. 1997, 38, 313.
232. Huang, X.; Seid, M.; Keillor, J. W. J. Org. Chem. 1997, 62, 7495.
233. Yamaguchi, J. I.; Hoshi, K.; Takeda, T. Chem. Lett. 1993, 1273.
234. Matsumara, Y.; Maki, T.; Satoh, Y. Tetrahedron Lett. 1997, 38, 8889.
235. Hiegel, G. A.; Hogenauer, T. J. Synth. Commun. 2005, 35, 2091.
236. Nishikawa, T.; Urabe, D.; Tomita, M.; Tsujimoto, T.; Iwabuchi, T.; Isobe, M. Org.
Lett. 2006, 8, 3263.
237. Gogoi, P.; Konwar, D. Tetrahedron Lett. 2007, 48, 531.
238. Palmieri, A.; Ley, S. V.; Hammond, K.; Polyzos, A.; Baxendale, I. R. Tetrahedron
Lett. 2009, 50, 3287.
239. (a) Smith, A. A. S. Org. React. 1946, 3, 337; (b) Scriven, E. F.; Turnbull, K. Chem.
Rev. 1988, 88, 297.
240. Richer, L. S.; Anderson, S. Tetrahedron Lett. 1998, 39, 8747.
241. Lebel, H.; Leogane, O. Org. Lett. 2005, 7, 4107.
242. Lebel, H.; Leogane, O. Org. Lett. 2006, 8, 5717.
243. Leogane, O.; Lebel, H. Synthesis 2009, 1935.
244. Dussault, P. H.; Xu, C. Tetrahedron Lett. 2004, 45, 7455.
245. Tada, T.; Ishida, Y.; Saigo, K. Synlett 2007, 235.
246. Sawada, D.; Sasayama, S.; Takahashi, H.; Iklegami, S. Tetrahedron Lett. 2006, 47, 7219.
247. Sawada, D.; Sasayama, S.; Takahashi, H.; Iklegami, S. Tetrahedron 2008, 64,
8780.
248. (a) Yale, H. L. Chem. Rev. 1943, 43, 209; (b) Bauer, L.; Exner, O. Angew. Chem.,
Int. Ed. Engl. 1974, 13, 376.
249. Hamon, F.; Prie, G.; Lecornue, F.; Papot, S. Tetrahedron Lett. 2009, 50, 6800.
250. Dube, P.; Nathel, N. F. F.; Vetelino, M.; Couturier, M.; Aboussafy, C. L.; Pichette,
S.; Jorgensen, M. L.; Hardink, M. Org. Lett. 2009, 11, 5622.
251. Fischer, W. Synthesis 2002, 29.
252. (a) Batey, R. A.; Ishii, C. Y.; Taylor, S. D.; Santhakumar, V. Tetrahedron Lett. 1999,
40, 2669; (b) Grzyb, J. A.; Batey, R. A. Tetrahedron Lett. 2008, 49, 5279.
253. Modarressi-Alam, A. R.; Rostamizahed, M.; Naja, P. Turk. J. Chem. 2006, 30,
269.
254. Modarressi-Alam, A. R.; Nasrollahzaden, M.; Khamooshi, F. ARKIVOC 2007, XVI,
238.
255. Modarressi-Alam, A. R.; Khamooshi, F.; Nasrollahzaden, M.; Amirazizi, H. A.
Tetrahedron 2007, 63, 8723.
256. Modarressi-Alam, A. R.; Nasrollahzaden, M.; Khamooshi, F. Sci. Iran. 2008, 15, 452.
257. Burgess, E. M.; Penton, H. R.; Taylor, E. A. J. Org. Chem. 1973, 38, 26.
258. Nicolaou, K. C.; Haung, X.; Snyder, S. A.; Rao, P. B.; Bella, M.; Reddy, M. V.
Angew. Chem., Int. Ed. 2002, 41, 834.
259. Wood, M. R.; Kim, J. Y.; Books, K. M. Tetrahedron Lett. 2002, 43, 3887.
260. Mamaghani, M.; Badrian, A. Tetrahedron Lett. 2004, 45, 1547.
261. Wicks, Z. Prog. Org. Coat. 1975, 3, 73.
262. Rannard, S. P.; Davis, N. J. Org. Lett. 2000, 2, 2117.
263. Jousseaume, B.; Laporte, C.; Toupance, T.; Bernard, J. M. Tetrahedron Lett. 2002, 43, 6305.
264. Vatele, J. M. Tetrahedron 2004, 60, 4251.
265. Li, Q. F.; Wang, J. W.; Dong, W. S.; Kang, M. Q.; Wang, X. K.; Peng, S. Y. J. Mol.
Catal. A: Chem. 2004, 212, 99.
266. Shimizu, M.; Sodoeka, M. Org. Lett. 2007, 9, 5231.
267. Wang, J.; Li, Q.; Dong, W.; Kang, M.; Wang, X.; Peng, S. Appl. Catal., A 2004, 261,191.
268. Sun, J.; Yang, B.; Lin, H. J. Chem. Technol. 2004, 27, 435.
269. Qin, F.; Li, Q.; Wang, J.; Feng, Y.; Kang, M.; Zhu, Y.; Wang, X. Catal. Lett. 2008,
126, 419.
270. Hall, A.; Huguet, E. P.; Jones, K. L.; Jones, T. C.; Killeen, N. M.; Yau, S. C.;
Tomkinson, N. C. O. Synlett 2007, 293.
271. Seijas, J. A.; Tato, M. P. V.; Campo, J. C. Synlett 2007, 2420.
272. Nair, V.; Mathew, S. C.; Biju, A. T.; Suresh, E. Tetrahedron Lett. 2007, 48, 9018.
273. Cardona, F.; Soldaini, G.; Goti, A. Synlett 2004, 1553.
274. Elghamry, I. Synth. Commun. 2009, 39, 3010.
Biographical sketch
Dr. Devdutt Chaturvedi obtained his Ph.D. degree, in Medicinal Chemistry, from the
Medicinal Chemistry Division of the Central Drug Research Institute (CSIR), Lucknow,
India, under the guidance of Dr. Suprabhat Ray, in 2003. His doctoral work was centred
on the design and synthesis of bioactive molecules using carbamates and related
chemistry by developing novel synthetic methodologies employing cheap and safe reagents, such as CO2/CS2. He worked as a Postdoctoral Fellow (2003e2005) at the University of Georgia, USA. Later, he worked as a Postdoctoral Fellow (2005e2006) at the
Institute of Organic Chemistry, University of Goettingen, Germany. He returned to India
and worked for a short period as a Senior Postdoctoral Fellow (2006e2007) at the Department of Chemistry, Indian Institute of Technology (I.I.T.), Madras and as a Scientist
Fellow (2007e2008) at the Bioorganic Chemistry Division, Indian Institute of Integrative Medicine (CSIR), Jammu. He has worked on several areas of organic synthesis and
medicinal chemistry, such as design and synthesis of novel classes of antidiabetic, antifertility, antitubercular, anti-inammatory, hypolipidemic, anti-HIV/HBV, anticancer,
antimalarial and antimicrobial agents, within which he has investigated various kinds
of structurally diverse synthetic/natural molecules, such as steroids, terpenoids, nucleosides, structurally diverse heterocycles, carbamates and related compounds. He has
published more than 50 research papers (containing more than 500 citations) in reputable international journals and has led 11 patents. He is a reviewer for several leading international journals, such as Tetrahedron Letters, Synlett, Synthesis, Chemistry:
An Asian Journal, European Journal of Organic Chemistry, Journal of Sulfur Chemistry,
Monatshefte fuer Chemie, European Journal of Medicinal Chemistry, Letters in Organic
Chemistry, Current Organic Synthesis, Current Organic Chemistry etc. His work has further been recognised by various kinds of awards, such as the Most Cited Paper Award
(2006e2009) for one of his Tetrahedron Letters publication, Young Scientist Award
(2008e2009) from the Govt. of Uttar Pradesh, Highest Impact Factor Award
(2009e2010) for publishing a review article in Chemical Society Reviews (I.F.26.58)
from the North-East Institute of Science and Technology (CSIR), Jorhat, Assam, India
and DST-Fast Track Young Scientist Award (2010) from the Govt. of India. Recently,
He has worked as a Guest Editor for publishing a hot topic issue entitled Organic Synthesis Using Green Reaction Media for a leading international journal Current Organic
Synthesis (I.F.3.95) published by Bentham Science Publishers, Ltd. He has also been
invited to become a member of editorial board for an international journal, ISRN Organic Chemistry Journal, published by Hindawi Publishers USA. He is presently working
at the Natural Products Chemistry Division of the North-East Institute of Science and
Technology (CSIR), Jorhat, Assam, India on the design and synthesis of novel classes
of bioactive natural/semisynthetic/synthetic molecules for the treatment of various
diseases employing novel synthetic methodologies and has been associated with the
chemistry and biology of organic carbamates for more than a decade.
45